Clinical Pharmacokinetics

, Volume 15, Issue 5, pp 287–294 | Cite as

Age-Related Changes in Liver Size and Hepatic Blood Flow

The Influence on Drug Metabolism in the Elderly
  • K. W. Woodhouse
  • H. A. Wynne
Review Article Clinical Pharmacokinetics and Disease Processes


The propensity of elderly people to suffer from dose-dependent adverse drug reactions is well known. This may be largely related to reduced drug clearance. Changes in liver size and liver blood flow are probably the main reason for this decline in drug elimination with age. This review focuses on methods of measuring liver size and blood flow, on changes which have been reported in the elderly and on the clinical implications of these changes.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Abernethy DR, Greenblatt DJ, Shader RI. Imipramine and desipramine disposition in the elderly. Journal of Pharmacology and Experimental Therapeutics 232: 183–188, 1985PubMedGoogle Scholar
  2. Antal EJ, Kramer PA, Mercik SA, Chapron DJ, Lawson IR. Theophylline pharmacokinetics in advanced age. British Journal of Clinical Pharmacology 12: 637–645, 1981PubMedCrossRefGoogle Scholar
  3. Bach B, Molholm Hansen J, Kampmann JP, Rasmussen SN, Skorsted L. Disposition of antipyrine and Phenytoin correlated with age and liver volume in man. Clinical Pharmacokinetics 6: 389–396, 1981PubMedCrossRefGoogle Scholar
  4. Bircher J, Blankart R, Halpern A, Haecki W, Laisue J, et al. Criteria for assessment of functional impairment in patients with cirrhosis of the liver. European Journal of Clinical Investigation 3: 72–85, 1973PubMedCrossRefGoogle Scholar
  5. Blendis LM, McNeilly WJ, Shepperd L, Williams R, et al. Observer variation in the clinical and radiological assessment of hepatosplenomegaly. British Medical Journal 1: 727–730, 1970PubMedCrossRefGoogle Scholar
  6. Boyd E. Normal variability in weight of the adult human liver and spleen. Archives of Pathology 16: 350–372, 1983Google Scholar
  7. Bradley SE, Ingelfinger FG, Bradley GP, Curry JJ. The estimation of hepatic blood flow in man. Journal of Clinical Investigation 24: 890–897, 1945CrossRefGoogle Scholar
  8. Branch RA, Shand DG, Wilkinson GR, Nies AS. Increased clearance of antipyrine and d-propanolol after phenobarbital treatment in the monkey. Journal of Clinical Investigations 53: 1101–1107, 1974CrossRefGoogle Scholar
  9. Calloway NO, Foley CF, Lagerbloom P. Uncertainties in geriatric data II: organ size. Journal of the American Geriatric Society 13: 20–28, 1965Google Scholar
  10. Carr D, Duncan JG, Railton R, Smith CB. Liver volume determination by ultrasound: a feasibility study. British Journal of Radiology 49: 776–778, 1976PubMedCrossRefGoogle Scholar
  11. Castleden CM, George CF. The effect of ageing on the hepatic clearance of propranolol. British Journal of Clinical Pharmacology 7: 49–54, 1979PubMedCrossRefGoogle Scholar
  12. Clarkson MJ, Hardy-Smith A, Richards TG. Measurement of liver blood flow by means of a simple injection of bromosulphthalein without hepatic venous catheterisation. Clinical Science and Molecular Medicine 51: 141–150, 1976PubMedGoogle Scholar
  13. Dunk AA, Jenkins WJ, Burroughs AK, Walt RP, Osuafor TOK, et al. The effect of ranitidine on the plasma clearance and hepatic extraction of indocyanine green in patients with chronic liver disease. British Journal of Clinical Pharmacology 16: 117–120, 1983PubMedCrossRefGoogle Scholar
  14. Editorial. Medication for the elderly. Journal of the Royal College of Physicians of London 18: 7–17, 1984Google Scholar
  15. Eikman EA, Mack GA, Jain VK, Madden JA. Computer-assisted liver mass estimation from gamma-camera images. Journal of Nuclear Medicine 20: 144–148, 1979PubMedGoogle Scholar
  16. Feely J, Crooks J, Stevenson IH. The influence of age, smoking and hyperthyroidism on plasma propranolol steady state concentration. British Journal of Clinical Pharmacology 12: 73–78, 1981PubMedCrossRefGoogle Scholar
  17. Feely J, Wade D, McAllister CB, Wilkinson GR, Robertson D. Effect of hypotension on liver blood flow and lidocaine disposition. New England Journal of Medicine 307: 866–869, 1982PubMedCrossRefGoogle Scholar
  18. Feely J, Wilkinson GR, Wood AJJ. Reduction of liver blood flow and propranolol metabolism by Cimetidine. New England Journal of Medicine 304: 692–695, 1980CrossRefGoogle Scholar
  19. Fritschy P, Robotti G, Schneckloth G, Vock P. Measurement of liver volume by ultrasound and computed tomography. Journal of Clinical Ultrasound 11: 299–303, 1983PubMedCrossRefGoogle Scholar
  20. George CF. Drug kinetics and hepatic blood flow. Clinical Pharmacokinetics 4: 433–448, 1979PubMedCrossRefGoogle Scholar
  21. Grainger SL, Kealing PWN, Brown IMH, Marigold JH, Thompson RPH. Clearance and non-invasive determination of the hepatic extraction of indocyanine green in baboons and man. Clinical Science 64: 207–212, 1983PubMedGoogle Scholar
  22. Grayson J, Johnson DH. The effect of adrenaline and noradrenaline on the liver blood flow. Journal of Physiology 120: 73–94, 1953PubMedGoogle Scholar
  23. Grayson J, Kinnear T. Observations on temperature, blood flow and heat production in the human liver in relation to environment and to glucose and insulin administration. Clinical Science 22: 125–140, 1962PubMedGoogle Scholar
  24. Greenblatt DJ, Divoll M, Abernethy DR, Harmatz JS, Shader RI. Antipyrine kinetics in the elderly: prediction of age related changes in benzodiazepine oxidising capacity. Journal of Pharmacology and Experimental Therapeutics 220: 120–126, 1982bPubMedGoogle Scholar
  25. Greenblatt DJ, Sellers EM, Shader RI. Drug disposition in old age. New England Journal of Medicine 306: 1081–1088, 1982aPubMedCrossRefGoogle Scholar
  26. Homeida M, Roberts CJC, Halliwell M, Read AE, Branch RA. Antipyrine clearance per unit volume liver: an assessment of hepatic function in chronic liver disease. Gut 20: 596–601, 1979PubMedCrossRefGoogle Scholar
  27. Hurwitz N. Predisposing factors in adverse reactions to drugs. British Medical Journal 1: 536–539, 1969PubMedCrossRefGoogle Scholar
  28. Iwamoto K, Watanabe J, Araki K, Deguchi N, Sugiyama H. Effect of age on hepatic clearance of propranolol in rats. Journal of Pharmacy and Pharmacology 37: 466–470, 1985PubMedCrossRefGoogle Scholar
  29. Kan MK, Hopkins GB. Measurement of liver volume by emission computed tomography. Journal of Nuclear Medicine 20: 514–520, 1979PubMedGoogle Scholar
  30. Kato R, Vassanelli P, Frontino G. Variation in the activity of liver microsomal drug metabolising enzymes in rats in relation to age. Biochemical Pharmacology 13: 1037–1051, 1964PubMedCrossRefGoogle Scholar
  31. Kitani K, Setsuko K, Miura R. Hepatic metabolism of sulfobromophthalein in ageing rats. In Kitani (Ed.) Liver and ageing, pp. 145–157, Elsevier Press, Amsterdam, 1978Google Scholar
  32. Kitani K, Zurcher C, Van Bezooijen K. The effect of ageing on the hepatic metabolism of sulfobromophthalein in BN/Bi female and WAG/Rij male and female rats. Mechanisms of Ageing and Development 7: 381–393, 1981CrossRefGoogle Scholar
  33. Kolin A. An electromagnetic flowmeter: principle of the method and its application to blood flow measurements. Proceedings of the Society of Experimental and Biological Medicine 35: 43–56, 1936Google Scholar
  34. Lebrec D, Goldfarb G, Benhamou JP. Reduction of liver blood flow by Cimetidine. New England Journal of Medicine 305: 100, 1981CrossRefGoogle Scholar
  35. Leevy CM, Mendenhall CL, Lesko W, Howard MM. Estimation of hepatic blood flow with indocyanine green. Journal of Clinical Investigation 41: 1169–1180, 1962PubMedCrossRefGoogle Scholar
  36. Leung NWY, Farrant P, Peters TJ. Liver volume measurement by ultrasonography in normal subjects and alcoholic patients. Journal of Hepatology 2: 157–164, 1986PubMedCrossRefGoogle Scholar
  37. Lorber SH, Oppenheimer MJ, Shay H, Lynch P, Siplet H. Enterohepatic circulation of bromosulphthalein in intraduodenal, intraportal and intravenous dye administration in dogs. American Journal of Physiology 173: 259–264, 1953PubMedGoogle Scholar
  38. Macnab MSP, Macrae DJ, Guy E, Grant IS, Feely J. Profound reduction in morphine clearance and liver blood flow in shock. Intensive Care Medicine 12: 366–369, 1986PubMedCrossRefGoogle Scholar
  39. Maloney AG, Schmucker DL, Vessey DS, Wang RK. The effects of ageing on the hepatic microsomal mixed-function oxidase system of male and female monkeys. Journal of Hepatology 6: 282–287, 1986CrossRefGoogle Scholar
  40. Meyhoff HH, Roder O, Andersen B. Palpatory estimation of liver size — within and between observer variation. Acta Chirurgica Scandinavica 145: 479–481, 1979PubMedGoogle Scholar
  41. Moriyasu F. A new method of transcutaneous measurement of portal blood flow by an ultrasonic ‘Duplex’ system composed of a pulsed doppler flowmeter and a linear-type real-time B-mode electroscanner. Acta Hepatology (Japan) 24: 537, 1983CrossRefGoogle Scholar
  42. Nation RL, Learoyd B, Barber J, Triggs EJ. The pharmacokinetics of chlormethiazole following intravenous administration in the aged. European Journal of Clinical Pharmacology 10: 407–415, 1976PubMedCrossRefGoogle Scholar
  43. Nation RL, Triggs EG, Selig M. Lignocaine kinetics in cardiac patients and aged subjects. British Journal of Clinical Pharmacology 4: 439–448, 1977PubMedCrossRefGoogle Scholar
  44. Ohnhaus EE. Methods of assessment of the effect of drugs on liver blood flow in man. British Journal of Clinical Pharmacology 7: 223–229, 1979PubMedCrossRefGoogle Scholar
  45. Ohnhaus EE, Locher JTh. Liver blood flow and blood volume following chronic phenobarbitone administration. European Journal of Pharmacology 31: 161–165, 1975PubMedCrossRefGoogle Scholar
  46. Pirttiaho HI, Sotaniemi EA, Ahokas JT, Pirkanen U. Liver size indices of drug metabolism in epileptics. British Journal of Clinical Pharmacology 6: 273–278, 1978PubMedCrossRefGoogle Scholar
  47. Raeth U, Johnson PJ, Williams R. Ultrasound determination of liver size and assessment of patients with malignant liver disease. Liver 4: 287–293, 1984PubMedGoogle Scholar
  48. Rasmussen SN. Liver volume determination by ultrasonic scanning. British Journal of Radiology 45: 579–585, 1972PubMedCrossRefGoogle Scholar
  49. Roberts RK, Branch RA, Desmond PV, Schenker S. The influence of liver disease on drug disposition. Clinics in Gastroenterology 8(1): 105–121, 1979PubMedGoogle Scholar
  50. Rollo FD, DeLand FH. The determination of liver mass from radionuclide images. Radiology 91: 1191–1194, 1968PubMedGoogle Scholar
  51. Salen SAM, Rajjayabu P, Sheperd AMM, Stevenson IH. Reduced induction of drug metabolism in the elderly. Age and Ageing 7: 68–73, 1978CrossRefGoogle Scholar
  52. Sato T, Miwa T, Tauchi H. Age changes in the human liver of different races. Gerontologia 16: 368–380, 1970PubMedCrossRefGoogle Scholar
  53. Schenk WG, McDonald JC, McDonald K, Drapanas T. Direct measurement of hepatic blood flow in experimental animals. Annals of Surgery 156: 463–471, 1962PubMedCrossRefGoogle Scholar
  54. Schnegg M, Lauterburg BH. Quantitative liver function in the elderly assessed by galactose elimination capacity, aminopyrine demethylation and caffeine clearance. Journal of Hepatology 3: 164–171, 1986PubMedCrossRefGoogle Scholar
  55. Sellers EM, Frecker RC, Romach MK. Drug metabolism in the elderly: confounding of age, smoking and ethanol effects. Drug Metabolism Reviews 14(2): 225–250, 1983PubMedCrossRefGoogle Scholar
  56. Sherlock S, Beam AG, Billing BH, Paterson JCS. Splanchnic blood flow in man by the bromsulfalein method: the relation of peripheral plasma bromsulfalein level to the calculated flow. Journal of Laboratory and Clinical Medicine 35: 923–932, 1950PubMedGoogle Scholar
  57. Spoelstra P, Teunissen MWE, Janssens AR, Weeda B, Van Duijn W. Antipyrine clearance and metabolite formation: the influence of liver volume and smoking. European Journal of Clinical Investigation 16: 321–327, 1986PubMedCrossRefGoogle Scholar
  58. Stadalnik RC, Vera DR, Woodle ES, Trudeau WL, Porter BA, et al. Technetium-99m NGA functional hepatic imaging preliminary clinical experience. Journal of Nuclear Medicine 26(11): 1233–1242, 1985PubMedGoogle Scholar
  59. Sutter MA, Wood G, Williamson LS, Strong R, Pickham K, et al. Comparison of the hepatic mixed function oxidase system of young, adult and old non-human primates (Macaca nemestrina). Biochemical Pharmacology 34: 2983–2987, 1985PubMedCrossRefGoogle Scholar
  60. Swift CG, Homeida M, Halliwell M, Roberts CJC. Antipyrine disposition and liver size in the elderly. European Journal of Clinical Pharmacology 14: 149–152, 1978PubMedCrossRefGoogle Scholar
  61. Thompson EN, Williams R. Effect of age on liver function with particular reference to bromsulphelein excretion. Gut 6: 266–269, 1965PubMedCrossRefGoogle Scholar
  62. Van Thiel DH, Hagler NG, Shade RR, Skolnick ML, Pollitt Heyl A, et al. In vivo hepatic volume determination using sonography and computed tomography. Gastroenterology 88: 1812–1817, 1985PubMedGoogle Scholar
  63. Vestal RE, Norris AH, Tobin JD, Cohen DH, Shock MW, et al. Antipyrine metabolism in man: influence of age, alcohol, caffeine and smoking. Clinical Pharmacology and Therapeutics 18: 425–432, 1975PubMedGoogle Scholar
  64. Vestal RE, Wood AJJ, Branch RA, Shand DG, Wilkinson GR. Effects of age and cigarette smoking on propranolol disposition. Clinical Pharmacology and Therapeutics 26(1): 8–15, 1979PubMedGoogle Scholar
  65. Vetter H, Falkner R, Neumayr A. The disappearance of colloidal radiogold from the circulation and its application to the estimation of liver blood flow in normal and cirrhotic subjects. Journal of Clinical Investigations 33: 1594–1602, 1954CrossRefGoogle Scholar
  66. Walk L. Liver size and its post-mortem changes. Radiologe 23: 189–191, 1983PubMedGoogle Scholar
  67. Weigand BD, Ketterer SG, Rapaport E. The use of indocyanine green for the evaluation of hepatic function and blood flow in man. American Journal of Digestive Diseases 5: 427–436, 1960CrossRefGoogle Scholar
  68. Wells PG, Feely J, Wilkinson GR, Wood AJJ. Effect of thyrotoxicosis on liver blood flow and propranolol disposition after long-term dosing. Clinical Pharmacology and Therapeutics 33(5): 603–608, 1983PubMedCrossRefGoogle Scholar
  69. Williams FM, Wynne HA, Woodhouse KW, Rawlins MD. Plasma aspirin esterase and cholinesterases in the elderly. British Journal of Clinical Pharmacology 24: 272P, 1987CrossRefGoogle Scholar
  70. Wood AJJ, Vestal RE, Wilkinson GR, Branch RA, Shand DG. Effect of ageing and cigarette smoking on antipyrine and indocyanine green elimination. Clinical Pharmacology and Therapeutics 26: 16–20, 1979PubMedGoogle Scholar
  71. Woodhouse KW, Mortimer O, Wiholm BE. Hepatic adverse drug reactions: the effect of age. In Liver and ageing: liver and brain, pp. 75–80, Elsevier, Amsterdam, 1986Google Scholar
  72. Woodhouse KW, Mutch E, Williams FM, James OFW. The effect of age on pathways of drug metabolism in human liver. Age and ageing 13: 328–334, 1984PubMedCrossRefGoogle Scholar
  73. Woodhouse KW, Williams F, Mutch E, Wynne H, Rawlins M, et al. Phase I drug metabolism in ageing. In Falk Symposium No. 47, Ageing and Gastrointestinal Tract, pp. 255–265, MTP Press, Lancaster, 1988Google Scholar
  74. Wynne HA, Cope LH, Mutch E, Rawlins MD, Woodhouse KW, et al. The effect of age upon liver volume and apparent liver blood flow in healthy man. Hepatology, in press, 1988bGoogle Scholar
  75. Wynne H, Mutch E, James OFW, Rawlins M, Woodhouse KW. Effect of age on monooxygenase enzyme kinetics in rat liver microsomes. Age and Ageing 16: 153–158, 1987PubMedCrossRefGoogle Scholar
  76. Wynne H, Mutch E, James OFW, Wright IP, Rawlins M, et al. The effect of age upon the affinity of microsomal monooxygenase enzymes for substrate in human liver. Age and Ageing, in press, 1988aGoogle Scholar
  77. Zoli M, Marchesini G, Melli A, et al. Evaluation of liver volume and liver function following hepatic resection in man. Liver 6: 286–291, 1986PubMedGoogle Scholar

Copyright information

© ADIS Press Limited 1988

Authors and Affiliations

  • K. W. Woodhouse
    • 1
  • H. A. Wynne
    • 1
  1. 1.Geriatric Pharmacology Research Group, Department of Medicine (Geriatrics) and Clinical PharmacologyUniversity of Newcastle upon TyneEngland

Personalised recommendations